NCT03846973View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

December 2, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

February 10, 2021

Conditions
Tranexamic Acid
Interventions
DRUG

Tranexamic Acid

intravenous infusion of 1 g infusion to be given and completed over 8 h in the hospital

OTHER

Placebo

placebo (normal saline) infusion to be given and completed over 8 h in the hospital

Trial Locations (1)

Unknown

Hamad General Hospital, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT03846973 - Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid | Biotech Hunter | Biotech Hunter